Vanda Pharmaceuticals Sees FY2026 Sales $230.000M-$260.000M vs $271.275M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Vanda Pharmaceuticals (NASDAQ:VNDA) sees FY2026 sales of $230.000 million-$260.000 million vs $271.275 million analyst estimate.
Vanda Pharmaceuticals (NASDAQ:VNDA) sees FY2026 sales of $230.000 million-$260.000 million vs $271.275 million analyst estimate.